# Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY

> **NCT04060849** · PHASE1 · TERMINATED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 10 (actual)

## Conditions studied

- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Solid Neoplasm

## Interventions

- **DRUG:** Nozin
- **OTHER:** Best Practice

## Key facts

- **NCT ID:** NCT04060849
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-03
- **Primary completion:** 2020-04-12
- **Final completion:** 2020-04-12
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** The study was closed to accrual according to the Fred Hutch/University of Washington/Seattle Children's Consortium low accrual institutional policy.
- **Last updated:** 2024-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04060849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04060849, "Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04060849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*